Tishenina R S, Kalinin A P, Khzardzhian V G, Mel'nikova E N
Probl Endokrinol (Mosk). 1988 Nov-Dec;34(6):32-8.
An increase in the number of diagnostic parameters (in addition to the determination of the urine level of 17-OCS, a study was also made of the level of 17-KS, blood concentrations of ACTH, prolactin, cortisol, and glucose before and after dexamethasone administration at a dose of 0.5 mg every 6 h for 2 days) and strict rules to be observed by examinees prepared for test performance made in possible to raise the differential-diagnostic role of Liddle's minor dexamethasone test. This conclusion was based on the examination of 34 persons without obesity, 25 patients with exogenous constitutional obesity, 75 patients with juvenile pubertal dyspituitarism, 107 patients with hypothalamic obesity, 8 patients with Cushing's syndrome determined by adrenal corticosteroma, one patient with ACTH-ectopic syndrome, and patients with Itsenko-Cushing disease (128 untreated patients, 99 patients with recurrence, 98 patients in remission). The comparison of clinico-instrumental results with the results of the test has shown its informative value for objective assessment of the gravity of disease. Stages of body responses to small doses of dexamethasone (the stage of lost responses, the stage of incomplete loss and the stage of recovered responses) were identified contributing to objective assessment of the gravity, course, presence, recurrence and remission of Itsenko-Cushing disease.
诊断参数数量的增加(除了测定尿17 - OCS水平外,还研究了17 - KS水平、促肾上腺皮质激素(ACTH)、催乳素、皮质醇的血浓度以及在2天内每6小时给予0.5毫克地塞米松前后的血糖浓度)以及应试者在准备测试时需遵守的严格规则,使得提高小剂量地塞米松试验的鉴别诊断作用成为可能。这一结论是基于对34名非肥胖者、25名外源性体质性肥胖患者、75名青少年青春期垂体功能减退患者、107名下丘脑性肥胖患者、8名由肾上腺皮质瘤确诊的库欣综合征患者、1名ACTH异位综合征患者以及艾森科 - 库欣病患者(128名未治疗患者、99名复发患者、98名缓解患者)的检查得出的。临床检查结果与该试验结果的比较显示了其对客观评估疾病严重程度的参考价值。确定了身体对小剂量地塞米松的反应阶段(反应丧失阶段、不完全丧失阶段和反应恢复阶段),有助于客观评估艾森科 - 库欣病的严重程度、病程、存在情况、复发和缓解情况。